BRD9 anticorps (AA 264-475)
-
- Antigène Voir toutes BRD9 Anticorps
- BRD9 (Bromodomain Containing 9 (BRD9))
-
Épitope
- AA 264-475
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp BRD9 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Purification
- Antigen Affinity Purified
- Immunogène
- Recombinant fragment corresponding to 264-475 aa of human BRD9.
- Isotype
- IgG
- Top Product
- Discover our top product BRD9 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- Lyophilized power with 1 % BSA and 0.02 % Sodium azide. Or dissolved in sterile H2O with 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C upon receipt. Avoid repeated freeze/thaw cycles.
-
- Antigène
- BRD9 (Bromodomain Containing 9 (BRD9))
- Autre désignation
- BRD9 (BRD9 Produits)
- Synonymes
- anticorps LAVS3040, anticorps PRO9856, anticorps AL022779, anticorps zgc:55797, anticorps BRD9, anticorps bromodomain containing 9, anticorps bromodomain containing 9 L homeolog, anticorps BRD9, anticorps Brd9, anticorps brd9, anticorps brd9.L
-